{"count": 32, "results": [{"_id": "32386485", "pmid": 32386485, "title": "Novel Targets of Metformin in Cardioprotection: Beyond the Effects Mediated by AMPK.", "journal": "Curr Pharm Des", "authors": ["Bolívar S", "Noriega L", "Ortega S", "Osorio E", "Rosales W", "Mendoza X", "Mendoza-Torres E"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1381612826666200509232610", "meta_date_publication": "2021", "meta_volume": "27", "meta_issue": "1", "meta_pages": "80-90", "score": 50262.727, "text_hl": "Further advances related to the biological effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and cardioprotective approaches may provide new therapies to protect the heart and prevent @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@cardiac remodeling@@@ and @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@.", "citations": {"NLM": "Bolívar S, Noriega L, Ortega S, Osorio E, Rosales W, Mendoza X, Mendoza-Torres E. Novel Targets of Metformin in Cardioprotection: Beyond the Effects Mediated by AMPK. Curr Pharm Des. 2021;27(1):80-90. PMID: 32386485", "BibTeX": "@article{32386485, title={Novel Targets of Metformin in Cardioprotection: Beyond the Effects Mediated by AMPK.}, author={Bolívar S and Noriega L and Ortega S and Osorio E and Rosales W and Mendoza X and Mendoza-Torres E}, journal={Curr Pharm Des}, volume={27}, number={1}, pages={80-90}}"}}, {"_id": "32742327", "pmid": 32742327, "pmcid": "PMC7388283", "title": "Metformin attenuates cardiac remodeling in mice through the Nrf2/Keap1 signaling pathway", "journal": "Exp Ther Med", "authors": ["Du J", "Zhu M", "Li H", "Liang G", "Li Y", "Feng S"], "date": "2020-08-01T00:00:00Z", "doi": "10.3892/etm.2020.8764", "meta_date_publication": "2020 Aug", "meta_volume": "20", "meta_issue": "2", "meta_pages": "838-845", "score": 50262.32, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@cardiac remodeling@@@ in @SPECIES_10090 @@@mice@@@ through the @GENE_NFE2L2 @GENE_18024 @@@Nrf2@@@/@GENE_KEAP1 @GENE_50868 @@@Keap1@@@ signaling pathway", "citations": {"NLM": "Du J, Zhu M, Li H, Liang G, Li Y, Feng S. Metformin attenuates cardiac remodeling in mice through the Nrf2/Keap1 signaling pathway Exp Ther Med. 2020 Aug;20(2):838-845. PMID: 32742327", "BibTeX": "@article{32742327, title={Metformin attenuates cardiac remodeling in mice through the Nrf2/Keap1 signaling pathway}, author={Du J and Zhu M and Li H and Liang G and Li Y and Feng S}, journal={Exp Ther Med}, volume={20}, number={2}, pages={838-845}}"}}, {"_id": "39253815", "pmid": 39253815, "title": "Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension.", "journal": "Acta Physiol (Oxf)", "authors": ["Wimmer MI", "Bartolomaeus H", "Anandakumar H", "Chen CY", "Vecera V", "Kedziora S", "Kamboj S", "Schumacher F", "Pals S", "Rauch A", "Meisel J", "Potapenko O", "Yarritu A", "Bartolomaeus TUP", "Samaan M", "Thiele A", "Stürzbecher L", "Geisberger SY", "Kleuser B", "Oefner PJ", "Haase N", "Löber U", "Gronwald W", "Forslund-Startceva SK", "Müller DN", "Wilck N"], "date": "2024-09-10T00:00:00Z", "doi": "10.1111/apha.14226", "meta_date_publication": "2024 Sep 10", "meta_volume": "", "meta_issue": "", "meta_pages": "e14226", "score": 50259.8, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ modulates microbiota and improves blood @DISEASE_Pressure_Ulcer @DISEASE_MESH:D003668 @@@pressure@@@ and @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@cardiac remodeling@@@ in a @SPECIES_10116 @@@rat@@@ model of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@.", "citations": {"NLM": "Wimmer MI, Bartolomaeus H, Anandakumar H, Chen CY, Vecera V, Kedziora S, Kamboj S, Schumacher F, Pals S, Rauch A, Meisel J, Potapenko O, Yarritu A, Bartolomaeus TUP, Samaan M, Thiele A, Stürzbecher L, Geisberger SY, Kleuser B, Oefner PJ, Haase N, Löber U, Gronwald W, Forslund-Startceva SK, Müller DN, Wilck N. Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension. Acta Physiol (Oxf). 2024 Sep 10;():e14226. PMID: 39253815", "BibTeX": "@article{39253815, title={Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension.}, author={Wimmer MI and Bartolomaeus H and Anandakumar H and Chen CY and Vecera V and Kedziora S and Kamboj S and Schumacher F and Pals S and Rauch A and Meisel J and Potapenko O and Yarritu A and Bartolomaeus TUP and Samaan M and Thiele A and Stürzbecher L and Geisberger SY and Kleuser B and Oefner PJ and Haase N and Löber U and Gronwald W and Forslund-Startceva SK and Müller DN and Wilck N}, journal={Acta Physiol (Oxf)}, pages={e14226}}"}}, {"_id": "34944478", "pmid": 34944478, "pmcid": "PMC8698925", "title": "Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence", "journal": "Biomolecules", "authors": ["Salvatore T", "Galiero R", "Caturano A", "Vetrano E", "Rinaldi L", "Coviello F", "Di Martino A", "Albanese G", "Marfella R", "Sardu C", "Sasso FC"], "date": "2021-12-04T00:00:00Z", "doi": "10.3390/biom11121834", "meta_date_publication": "2021 Dec 4", "meta_volume": "11", "meta_issue": "12", "meta_pages": "", "score": 50250.438, "text_hl": "In these experimental models, @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activation by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ repressed @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@cardiac remodeling@@@ and rescued cardiac function.", "citations": {"NLM": "Salvatore T, Galiero R, Caturano A, Vetrano E, Rinaldi L, Coviello F, Di Martino A, Albanese G, Marfella R, Sardu C, Sasso FC. Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence Biomolecules. 2021 Dec 4;11(12):. PMID: 34944478", "BibTeX": "@article{34944478, title={Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence}, author={Salvatore T and Galiero R and Caturano A and Vetrano E and Rinaldi L and Coviello F and Di Martino A and Albanese G and Marfella R and Sardu C and Sasso FC}, journal={Biomolecules}, volume={11}, number={12}}"}}, {"_id": "36614028", "pmid": 36614028, "pmcid": "PMC9820506", "title": "Metformin Attenuates Hyperglycaemia-Stimulated Pro-Fibrotic Gene Expression in Adventitial Fibroblasts via Inhibition of Discoidin Domain Receptor 2", "journal": "Int J Mol Sci", "authors": ["Titus AS", "Ushakumary MG", "Venugopal H", "Wang M", "Lakatta EG", "Kailasam S"], "date": "2022-12-29T00:00:00Z", "doi": "10.3390/ijms24010585", "meta_date_publication": "2022 Dec 29", "meta_volume": "24", "meta_issue": "1", "meta_pages": "", "score": 50245.87, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is reported to reduce the long-term complications of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, including @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular fibrosis@@@ and @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@remodelling@@@. ", "citations": {"NLM": "Titus AS, Ushakumary MG, Venugopal H, Wang M, Lakatta EG, Kailasam S. Metformin Attenuates Hyperglycaemia-Stimulated Pro-Fibrotic Gene Expression in Adventitial Fibroblasts via Inhibition of Discoidin Domain Receptor 2 Int J Mol Sci. 2022 Dec 29;24(1):. PMID: 36614028", "BibTeX": "@article{36614028, title={Metformin Attenuates Hyperglycaemia-Stimulated Pro-Fibrotic Gene Expression in Adventitial Fibroblasts via Inhibition of Discoidin Domain Receptor 2}, author={Titus AS and Ushakumary MG and Venugopal H and Wang M and Lakatta EG and Kailasam S}, journal={Int J Mol Sci}, volume={24}, number={1}}"}}, {"_id": "34662551", "pmid": 34662551, "title": "Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance beta-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin.", "journal": "Life Sci", "authors": ["Ibrahim WS", "Ahmed HMS", "Mahmoud AAA", "Mahmoud MF", "Ibrahim IAAE"], "date": "2021-12-01T00:00:00Z", "doi": "10.1016/j.lfs.2021.120055", "meta_date_publication": "2021 Dec 1", "meta_volume": "286", "meta_issue": "", "meta_pages": "120055", "score": 50244.832, "text_hl": "SIGNIFICANCE: @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@Propranolol@@@ and L-D-ISOPROT, like @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, can reduce @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin-resistance@@@ and @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@cardiac remodeling@@@ in HFrHFD-fed @SPECIES_10090 @@@mice@@@, possibly by upregulating beta-arrestin2 signaling activity. ", "citations": {"NLM": "Ibrahim WS, Ahmed HMS, Mahmoud AAA, Mahmoud MF, Ibrahim IAAE. Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance beta-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin. Life Sci. 2021 Dec 1;286():120055. PMID: 34662551", "BibTeX": "@article{34662551, title={Propranolol and low-dose isoproterenol ameliorate insulin resistance, enhance beta-arrestin2 signaling, and reduce cardiac remodeling in high-fructose, high-fat diet-fed mice: Comparative study with metformin.}, author={Ibrahim WS and Ahmed HMS and Mahmoud AAA and Mahmoud MF and Ibrahim IAAE}, journal={Life Sci}, volume={286}, pages={120055}}"}}, {"_id": "37816240", "pmid": 37816240, "title": "Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial.", "journal": "Metab Syndr Relat Disord", "authors": ["Kamel AM", "Ismail B", "Abdel Hafiz G", "Sabry N", "Farid S"], "date": "2023-10-10T00:00:00Z", "doi": "10.1089/met.2023.0164", "meta_date_publication": "2023 Oct 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50243.562, "text_hl": "We hypothesized that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might improve oxidative stress and @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@left ventricular remodeling@@@ in nondiabetic @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@HF@@@ patients with reduced ejection fraction (HFrEF). ", "citations": {"NLM": "Kamel AM, Ismail B, Abdel Hafiz G, Sabry N, Farid S. Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial. Metab Syndr Relat Disord. 2023 Oct 10;():. PMID: 37816240", "BibTeX": "@article{37816240, title={Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial.}, author={Kamel AM and Ismail B and Abdel Hafiz G and Sabry N and Farid S}, journal={Metab Syndr Relat Disord}}"}}, {"_id": "34539827", "pmid": 34539827, "pmcid": "PMC8438677", "title": "Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway", "journal": "Exp Ther Med", "authors": ["Du F", "Cao Y", "Ran Y", "Wu Q", "Chen B"], "date": "2021-11-01T00:00:00Z", "doi": "10.3892/etm.2021.10665", "meta_date_publication": "2021 Nov", "meta_volume": "22", "meta_issue": "5", "meta_pages": "1231", "score": 50241.008, "text_hl": "In the @CELLLINE_CVCL:0286 @@@H9C2@@@, treatment with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ attenuated @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@hypertrophic remodeling@@@. ", "citations": {"NLM": "Du F, Cao Y, Ran Y, Wu Q, Chen B. Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway Exp Ther Med. 2021 Nov;22(5):1231. PMID: 34539827", "BibTeX": "@article{34539827, title={Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway}, author={Du F and Cao Y and Ran Y and Wu Q and Chen B}, journal={Exp Ther Med}, volume={22}, number={5}, pages={1231}}"}}, {"_id": "31969144", "pmid": 31969144, "pmcid": "PMC6977298", "title": "Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis", "journal": "Cardiovasc Diabetol", "authors": ["Zhang DP", "Xu L", "Wang LF", "Wang HJ", "Jiang F"], "date": "2020-01-22T00:00:00Z", "doi": "10.1186/s12933-020-0987-x", "meta_date_publication": "2020 Jan 22", "meta_volume": "19", "meta_issue": "1", "meta_pages": "10", "score": 50231.676, "text_hl": "The mitigation of @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@left ventricular (LV) remodeling@@@ was paralleled by improvements in LV systolic performance. ", "citations": {"NLM": "Zhang DP, Xu L, Wang LF, Wang HJ, Jiang F. Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis Cardiovasc Diabetol. 2020 Jan 22;19(1):10. PMID: 31969144", "BibTeX": "@article{31969144, title={Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis}, author={Zhang DP and Xu L and Wang LF and Wang HJ and Jiang F}, journal={Cardiovasc Diabetol}, volume={19}, number={1}, pages={10}}"}}, {"_id": "40865704", "pmid": 40865704, "title": "Immune mitochondrial complex I mediates vascular damage in toll-like receptor 7 (TLR7)-induced lupus.", "journal": "Pharmacol Res", "authors": ["Miñano S", "Moleón J", "González-Correa C", "Robles-Vera I", "Gómez-Guzmán M", "Sánchez M", "Bayraktar S", "Visitación N", "Martín-Morales N", "O'Valle F", "Romero M", "Sancho D", "Toral M", "Duarte J"], "date": "2025-08-25T00:00:00Z", "doi": "10.1016/j.phrs.2025.107910", "meta_date_publication": "2025 Aug 25", "meta_volume": "220", "meta_issue": "", "meta_pages": "107910", "score": 50228.44, "text_hl": "Pharmacological dual inhibition of glycolysis with @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2-deoxy-D-glucose@@@ and mitochondrial metabolism with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ further supports the therapeutic potential of metabolic targeting, improving vascular function and preventing @<m>DISEASE_Ventricular_Remodeling</m> @DISEASE_MESH:D020257 @@@aortic remodeling@@@, characterized by proteoglycan and collagen accumulation, increased aortic stiffness, and secretory and profibrotic phenotypes. ", "citations": {"NLM": "Miñano S, Moleón J, González-Correa C, Robles-Vera I, Gómez-Guzmán M, Sánchez M, Bayraktar S, Visitación N, Martín-Morales N, O'Valle F, Romero M, Sancho D, Toral M, Duarte J. Immune mitochondrial complex I mediates vascular damage in toll-like receptor 7 (TLR7)-induced lupus. Pharmacol Res. 2025 Aug 25;220():107910. PMID: 40865704", "BibTeX": "@article{40865704, title={Immune mitochondrial complex I mediates vascular damage in toll-like receptor 7 (TLR7)-induced lupus.}, author={Miñano S and Moleón J and González-Correa C and Robles-Vera I and Gómez-Guzmán M and Sánchez M and Bayraktar S and Visitación N and Martín-Morales N and O'Valle F and Romero M and Sancho D and Toral M and Duarte J}, journal={Pharmacol Res}, volume={220}, pages={107910}}"}}]}